Published in Genes Dev on November 27, 2013
NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell (2014) 2.62
The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol Cell (2014) 2.47
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature (2014) 2.33
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med (2014) 2.08
Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science (2015) 1.95
Looping back to leap forward: transcription enters a new era. Cell (2014) 1.93
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat Biotechnol (2015) 1.83
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Nature (2015) 1.75
Genomic spectra of biliary tract cancer. Nat Genet (2015) 1.58
A chemical probe toolbox for dissecting the cancer epigenome. Nat Rev Cancer (2017) 1.40
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia. Mol Cell (2015) 1.36
MYC, Metabolism, and Cancer. Cancer Discov (2015) 1.29
Vulnerabilities of mutant SWI/SNF complexes in cancer. Cancer Cell (2014) 1.20
A rationale to target the SWI/SNF complex for cancer therapy. Trends Genet (2014) 1.17
Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia. Proc Natl Acad Sci U S A (2014) 1.15
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Nat Genet (2015) 1.10
Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. J Clin Invest (2015) 1.03
Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies. Neuro Oncol (2016) 1.02
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies. Cancer Res (2015) 0.99
NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. Mol Cell (2015) 0.98
Brg1 modulates enhancer activation in mesoderm lineage commitment. Development (2015) 0.94
The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth. Nat Immunol (2015) 0.93
RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis. Cancer Discov (2014) 0.93
Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. Cancer Discov (2015) 0.91
Endoplasmic reticulum stress, genome damage, and cancer. Front Oncol (2015) 0.90
Chromatin Remodelers: From Function to Dysfunction. Genes (Basel) (2015) 0.86
Transcription-coupled recruitment of human CHD1 and CHD2 influences chromatin accessibility and histone H3 and H3.3 occupancy at active chromatin regions. Epigenetics Chromatin (2015) 0.86
A hyperactive transcriptional state marks genome reactivation at the mitosis-G1 transition. Genes Dev (2016) 0.86
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance. Sci Adv (2015) 0.86
Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis. Cancers (Basel) (2014) 0.85
BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements. Cell Rep (2016) 0.85
Leukaemia cell of origin identified by chromatin landscape of bulk tumour cells. Nat Commun (2016) 0.85
Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration. Blood Cancer J (2015) 0.85
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition. Nat Chem Biol (2016) 0.84
SWI/SNF proteins as targets in cancer therapy. J Hematol Oncol (2014) 0.84
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia. Exp Hematol (2014) 0.84
Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex. Cell (2016) 0.83
The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer. Elife (2015) 0.82
The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. J Cell Physiol (2015) 0.81
A SWI/SNF Chromatin Remodelling Protein Controls Cytokinin Production through the Regulation of Chromatin Architecture. PLoS One (2015) 0.80
SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance. PLoS One (2015) 0.80
Uncovering enhancer functions using the α-globin locus. PLoS Genet (2014) 0.79
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case. Cold Spring Harb Mol Case Stud (2015) 0.79
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. Elife (2016) 0.79
Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells. Oncotarget (2016) 0.79
Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer. Mol Cancer (2017) 0.79
Signal transducer and activator of transcription STAT5 is recruited to c-Myc super-enhancer. BMC Mol Biol (2016) 0.78
BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo. Cardiovasc Pathol (2016) 0.78
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers. Nat Genet (2017) 0.77
SMARCA4 regulates gene expression and higher-order chromatin structure in proliferating mammary epithelial cells. Genome Res (2016) 0.77
Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage. J Am Soc Nephrol (2016) 0.77
BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways. Oncogene (2016) 0.76
Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis. Oncotarget (2016) 0.76
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC. J Neurovirol (2016) 0.76
Erythropoiesis provides a BRD's eye view of BET protein function. Drug Discov Today Technol (2016) 0.76
Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nat Genet (2017) 0.76
SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanism. Nat Genet (2017) 0.76
Induction of functional Brm protein from Brm knockout mice. Oncoscience (2015) 0.76
Enhancer deregulation in cancer and other diseases. Bioessays (2016) 0.76
MYC Deregulation in Primary Human Cancers. Genes (Basel) (2017) 0.75
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation. Oncotarget (2016) 0.75
Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis (2016) 0.75
BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility. J Mol Cell Cardiol (2017) 0.75
Distinct epigenetic signatures elucidate enhancer-gene relationships that delineate CIMP and non-CIMP colorectal cancers. Oncotarget (2016) 0.75
High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML. Cell Rep (2016) 0.75
SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development. Oncogene (2016) 0.75
Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language. Yale J Biol Med (2016) 0.75
Transcriptional Addiction in Cancer. Cell (2017) 0.75
IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep (2016) 0.75
An oncogenic enhancer enemy (N-Me) in T-ALL. Cell Cycle (2015) 0.75
Amplification of the bromodomain-containing protein 4 gene in ovarian high-grade serous carcinoma is associated with worse prognosis and survival. Mol Clin Oncol (2015) 0.75
Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells. Int J Mol Sci (2017) 0.75
Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2017) 0.75
The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers. Nat Commun (2017) 0.75
Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling. Genes (Basel) (2017) 0.75
MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation. Cell Cycle (2016) 0.75
The roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemia. Biomed Res Int (2015) 0.75
Mammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming. Front Oncol (2017) 0.75
Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression. Redox Biol (2016) 0.75
lncRNA requirements for mouse acute myeloid leukemia and normal differentiation. Elife (2017) 0.75
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes. Mol Cell (2017) 0.75
CHD1 regulates cell fate determination by activation of differentiation-induced genes. Nucleic Acids Res (2017) 0.75
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity. Trends Cancer (2017) 0.75
BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines. Clin Transl Oncol (2017) 0.75
The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia. Cold Spring Harb Symp Quant Biol (2017) 0.75
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nat Immunol (2017) 0.75
Cancer and Aging - the Inflammatory Connection. Aging Dis (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Selective inhibition of BET bromodomains. Nature (2010) 18.79
Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23
BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34
A unique chromatin signature uncovers early developmental enhancers in humans. Nature (2010) 14.02
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature (2011) 11.44
A map of the cis-regulatory sequences in the mouse genome. Nature (2012) 8.74
Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell (2013) 8.37
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature (2011) 8.29
Lessons from the cancer genome. Cell (2013) 8.12
Cancer epigenetics: from mechanism to therapy. Cell (2012) 7.74
Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science (1994) 7.17
SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer (2011) 6.87
BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature (1993) 6.41
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J (1996) 6.36
Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A (2011) 6.30
Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell (2010) 5.05
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res (2011) 4.91
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell (2011) 4.56
DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol (2008) 4.56
Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol (2007) 4.27
Understanding the words of chromatin regulation. Cell (2009) 3.67
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet (2013) 3.51
Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat Biotechnol (2010) 3.33
Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus. Mol Cell (2008) 3.24
Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell (2003) 3.06
Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2006) 3.04
The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol (2011) 3.01
A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell (1999) 2.73
Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleosome arrays. Mol Cell (1999) 2.63
Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity (2003) 2.56
Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell (2002) 2.51
Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat Methods (2012) 2.42
Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature (2002) 2.41
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol (2005) 2.41
An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev (2011) 2.38
Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev (2001) 2.00
The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS One (2013) 2.00
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood (2005) 1.96
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 1.92
Determining long-range chromatin interactions for selected genomic sites using 4C-seq technology: from fixation to computation. Methods (2012) 1.85
Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. Cancer Res (2009) 1.82
A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development. Genes Dev (2005) 1.81
Identification of a polymorphic, neuron-specific chromatin remodeling complex. Genes Dev (2002) 1.80
Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J Proteome Res (2006) 1.64
BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature (2013) 1.52
Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry (2007) 1.51
Emerging epigenetic targets and therapies in cancer medicine. Cancer Discov (2012) 1.43
Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene (2006) 1.37
The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function. Blood (2012) 1.13
Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res (1999) 1.10
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations. Blood (2012) 1.09
Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart. Circ Res (2012) 1.06
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. J Natl Cancer Inst (2008) 1.04
The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J Cell Physiol (2010) 1.01
A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. Blood (2010) 0.97
Transcriptional regulatory networks in Saccharomyces cerevisiae. Science (2002) 43.52
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Control of developmental regulators by Polycomb in human embryonic stem cells. Cell (2006) 28.21
Strong association of de novo copy number mutations with autism. Science (2007) 27.84
Transcriptional regulatory code of a eukaryotic genome. Nature (2004) 27.21
Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90
A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell (2008) 16.38
Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A (2010) 15.13
Genome-wide map of nucleosome acetylation and methylation in yeast. Cell (2005) 15.08
Mediator and cohesin connect gene expression and chromatin architecture. Nature (2010) 14.34
BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34
Control of pancreas and liver gene expression by HNF transcription factors. Science (2004) 12.05
Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol Cell (2003) 11.78
c-Myc regulates transcriptional pause release. Cell (2010) 11.64
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature (2011) 11.44
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell (2003) 11.40
Divergent transcription from active promoters. Science (2008) 11.03
E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev (2002) 10.06
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat Genet (2007) 9.56
Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell (2013) 9.55
Long noncoding RNAs: functional surprises from the RNA world. Genes Dev (2009) 9.14
WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell (2005) 8.86
Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell (2013) 8.37
Transcriptional amplification in tumor cells with elevated c-Myc. Cell (2012) 8.24
From silencing to gene expression: real-time analysis in single cells. Cell (2004) 7.73
Super-enhancers in the control of cell identity and disease. Cell (2013) 7.50
Mapping human genetic diversity in Asia. Science (2009) 7.40
Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc (2006) 7.29
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell (2011) 7.03
Nuclear speckles: a model for nuclear organelles. Nat Rev Mol Cell Biol (2003) 6.98
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A (2006) 6.80
Computational discovery of gene modules and regulatory networks. Nat Biotechnol (2003) 6.55
Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays. Nat Genet (2004) 6.33
Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A (2005) 6.26
Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13
Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell (2005) 6.12
Inferring tumor progression from genomic heterogeneity. Genome Res (2009) 6.09
Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol (2006) 6.03
Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell (2005) 5.96
Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature (2007) 5.81
Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron (2011) 5.78
Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1. Mol Cell (2005) 5.77
Regulating gene expression through RNA nuclear retention. Cell (2005) 5.58
Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A (2005) 5.53
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell (2008) 5.47
Human PAD4 regulates histone arginine methylation levels via demethylimination. Science (2004) 5.46
Chromatin structure analyses identify miRNA promoters. Genes Dev (2008) 5.40
Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell (2004) 5.30
Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A (2002) 5.18
53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature (2008) 5.11
MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res (2008) 5.06
The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res (2012) 5.04
Profile of histone lysine methylation across transcribed mammalian chromatin. Mol Cell Biol (2006) 5.01
Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet (2006) 4.97
Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev (2008) 4.77
Whole-genome ChIP-chip analysis of Dorsal, Twist, and Snail suggests integration of diverse patterning processes in the Drosophila embryo. Genes Dev (2007) 4.59
Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell (2010) 4.59
Dynamics of single mRNPs in nuclei of living cells. Science (2004) 4.58
DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol (2008) 4.56
3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell (2008) 4.54
The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet (2010) 4.46
Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell (2008) 4.43
Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends Biochem Sci (2005) 4.37
Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol Cell (2010) 4.36
Exchange of RNA polymerase II initiation and elongation factors during gene expression in vivo. Mol Cell (2002) 4.35
Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. Genes Dev (2007) 4.34
Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell (2010) 4.32
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med (2008) 4.25
Global regulation of erythroid gene expression by transcription factor GATA-1. Blood (2004) 4.22
An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol (2012) 4.15
Program-specific distribution of a transcription factor dependent on partner transcription factor and MAPK signaling. Cell (2003) 4.12
Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol (2005) 4.11
SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev (2009) 4.09
S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell (2003) 4.03
Activated signal transduction kinases frequently occupy target genes. Science (2006) 4.01
The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell (2002) 3.99
Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature (2013) 3.98
Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell (2011) 3.94
Genome-wide location and regulated recruitment of the RSC nucleosome-remodeling complex. Genes Dev (2002) 3.93
H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell (2008) 3.90
RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell (2009) 3.82
High-resolution computational models of genome binding events. Nat Biotechnol (2006) 3.74
Global position and recruitment of HATs and HDACs in the yeast genome. Mol Cell (2004) 3.74
Regulation of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol (2004) 3.70
A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell (2011) 3.69
Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature (2012) 3.67
Revisiting global gene expression analysis. Cell (2012) 3.63
Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat Genet (2001) 3.63
Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell (2013) 3.61
Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature (2008) 3.55